INMEST Platform

About Abilion Medical Systems

Abilion Medical Systems is a private, pre-revenue medical device developer pioneering a novel, non-pharmacological treatment for migraine and other conditions. Its core technology, INMEST, uses gentle mechanical stimulation of intranasal nerves to modulate the autonomic nervous system and influence immune regulation, specifically targeting regulatory T-cells (Tregs). The company is developing a connected system comprising a handheld device, mobile app, and cloud platform to enable monitored home-based treatment, aiming to address the significant unmet needs in migraine care related to drug side effects and poor treatment adherence.

Therapeutic Areas